MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice

Cancer Cell

Volumn 3, Issue 2, 2003, Pages 161-171

  So, Chi Wai ^a   Karsunky, Holger ^a   Passegué, Emmanuelle ^a   Cozzio, Antonio ^a   Weissman, Irving L ^a   Cleary, Michael L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; CYTOKINE; DNA BINDING PROTEIN; GAS7 PROTEIN, HUMAN; GAS7 PROTEIN, MOUSE; MEMBRANE ANTIGEN; MESSENGER RNA; MIXED LINEAGE LEUKEMIA PROTEIN; MLL PROTEIN, HUMAN; MLL PROTEIN, MOUSE; NERVE PROTEIN; ONCOPROTEIN; RNA; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER GENETICS; CELL DIFFERENTIATION; CELL GROWTH; CELL LINEAGE; GENETIC TRANSCRIPTION; GENETIC TRANSFORMATION; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOPHENOTYPING; IN VITRO STUDY; LEUKEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL; ANIMAL; C57BL MOUSE; CELL TRANSFORMATION; CHEMICALLY INDUCED DISORDER; GENETICS; METABOLISM; PATHOLOGY; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALIA; MURINAE;

ANIMALS; ANTIGENS, SURFACE; BLOTTING, WESTERN; CELL LINEAGE; CELL TRANSFORMATION, NEOPLASTIC; CYTOKINES; DNA-BINDING PROTEINS; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA; MICE; MICE, INBRED C57BL; MYELOID-LYMPHOID LEUKEMIA PROTEIN; NERVE TISSUE PROTEINS; ONCOGENE PROTEINS, FUSION; PROTO-ONCOGENES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TRANSCRIPTION FACTORS;

EID: 0042872887     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(03)00019-9     Document Type: Article

References (37)

1. Akashi K., Traver D., Miyamoto T., Weissman I.L. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 404:2000;193-197.
2. Armstrong S.A., Staunton J.E., Silverman L.B., Pieters R., den Boer M.L., Minden M.D., Sallan S.E., Lander E.S., Golub T.R., Korsmeyer S.J. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat. Genet. 30:2002;41-47.
3. Ayton P.M., Cleary M.L. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene. 20:2001;5695-5707.
4. Borrello M.A., Palis J., Phipps R.P. The relationship of CD5+ B lymphocytes to macrophages. insights from normal biphenotypic B/macrophage cells Int. Rev. Immunol. 20:2001;137-155.
5. Chen C.S., Sorensen P.H., Domer P.H., Reaman G.H., Korsmeyer S.J., Heerema N.A., Hammond G.D., Kersey J.H. Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome. Blood. 81:1993;2386-2393.
6. Christensen J.L., Weissman I.L. Flk-2 is a marker in hematopoietic stem cell differentiation. a simple method to isolate long-term stem cells Proc. Natl. Acad. Sci. USA. 98:2001;14541-14546.
7. Corral J., Lavenir I., Impey H., Warren A.J., Forster A., Larson T.A., Bell S., McKenzie A.N., King G., Rabbitts T.H. An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice, a method to create fusion oncogenes. Cell. 85:1996;853-861.
8. Cumano A., Paige C.J., Iscove N.N., Brady G. Bipotential precursors of B cells and macrophages in murine fetal liver. Nature. 356:1992;612-615.
9. DiMartino J.F., Ayton P.M., Chen E.H., Naftzger C.C., Young B.D., Cleary M.L. The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10. Blood. 99:2002;3780-3785.
10. Djabali M., Selleri L., Parry P., Bower M., Young B.D., Evans G.A. A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukaemias. Nat. Genet. 2:1992;113-118.
11. Dobson C.L., Warren A.J., Pannell R., Forster A., Lavenir I., Corral J., Smith A.J., Rabbitts T.H. The mll-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis. EMBO J. 18:1999;3564-3574.
12. Enver T., Greaves M. Loops, lineage, and leukemia. Cell. 94:1998;9-12.
13. Greaves M.F., Chan L.C., Furley A.J., Watt S.M., Molgaard H.V. Lineage promiscuity in hemopoietic differentiation and leukemia. Blood. 67:1986;1-11.
14. Gu Y., Nakamura T., Alder H., Prasad R., Canaani O., Cimino G., Croce C.M., Canaani E. The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell. 71:1992;701-708.
15. Hardy R.R., Carmack C.E., Shinton S.A., Kemp J.D., Hayakawa K. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173:1991;1213-1225.
16. Hu M., Krause D., Greaves M., Sharkis S., Dexter M., Heyworth C., Enver T. Multilineage gene expression precedes commitment in the hemopoietic system. Genes Dev. 11:1997;774-785.
17. Kondo M., Weissman I.L., Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell. 91:1997;661-672.
18. Kondo M., Scherer D.C., Miyamoto T., King A.G., Akashi K., Sugamura K., Weissman I.L. Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines. Nature. 407:2000;383-386.
19. Lavau C., Szilvassy S.J., Slany R., Cleary M.L. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL. EMBO J. 16:1997;4226-4237.
20. Lavau C., Du C., Thirman M., Zeleznik-Le N. Chromatin-related properties of CBP fused to MLL generate a myelodysplastic-like syndrome that evolves into myeloid leukemia. EMBO J. 19:2000;4655-4664.
21. Luo R.T., Lavau C., Du C., Simone F., Polak P.E., Kawamata S., Thirman M.J. The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis. Mol. Cell. Biol. 21:2001;5678-5687.
22. McCabe N.R., Burnett R.C., Gill H.J., Thirman M.J., Mbangkollo D., Kipiniak M., van Melle E., Ziemin-van der Poel S., Rowley J.D., Diaz M.O. Cloning of cDNAs of the MLL gene that detect DNA rearrangements and altered RNA transcripts in human leukemic cells with 11q23 translocations. Proc. Natl. Acad. Sci. USA. 89:1992;11794-11798.
23. McCulloch E.A. Stem cells in normal and leukemic hemopoiesis (Henry Stratton Lecture, 1982). Blood. 62:1983;1-13.
24. Megonigal M.D., Cheung N.K., Rappaport E.F., Nowell P.C., Wilson R.B., Jones D.H., Addya K., Leonard D.G., Kushner B.H., Williams T.M., et al. Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors. Proc. Natl. Acad. Sci. USA. 97:2000;2814-2819.
25. Miyamoto T., Weissman I.L., Akashi K. AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc. Natl. Acad. Sci. USA. 97:2000;7521-7526.
26. Montecino-Rodriguez E., Leathers H., Dorshkind K. Bipotential B-macrophage progenitors are present in adult bone marrow. Nat. Immunol. 2:2001;83-88.
27. Morrison S.J., Weissman I.L. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity. 1:1994;661-673.
28. Morrison S.J., Wandycz A.M., Hemmati H.D., Wright D.E., Weissman I.L. Identification of a lineage of multipotent hematopoietic progenitors. Development. 124:1997;1929-1939.
29. Pui C.H., Gaynon P.S., Boyett J.M., Chessells J.M., Baruchel A., Kamps W., Silverman L.B., Biondi A., Harms D.O., Vilmer E., et al. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet. 359:2002;1909-1915.
30. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature. 414:2001;105-111.
31. Schulte C.E., von Lindern M., Steinlein P., Beug H., Wiedemann L.M. MLL-ENL cooperates with SCF to transform primary avian multipotent cells. EMBO J. 21:2002;4297-4306.
32. So C.W., Cleary M.L. MLL-AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein function. Mol. Cell. Biol. 22:2002;6542-6552.
33. So C.W., Cleary M.L. Common mechanism for oncogenic activation of MLL by forkhead family proteins. Blood. 101:2003;633-639.
34. Tkachuk D.C., Kohler S., Cleary M.L. Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell. 71:1992;691-700.
35. Traver D., Akashi K., Manz M., Merad M., Miyamoto T., Engleman E.G., Weissman I.L. Development of CD8alpha-positive dendritic cells from a common myeloid progenitor. Science. 290:2000;2152-2154.
36. Yeoh E.J., Ross M.E., Shurtleff S.A., Williams W.K., Patel D., Mahfouz R., Behm F.G., Raimondi S.C., Relling M.V., Patel A., et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell. 1:2002;133-143.
37. Zhu J., Emerson S.G. Hematopoietic cytokines, transcription factors and lineage commitment. Oncogene. 21:2002;3295-3313.